Instil Bio Announces Strategic UpdateGlobe Newswire • 4 months agoDALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ( Instil or the Company ) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte...